Pyoderma gangrenosum following reduction mammoplasty: a case report

Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis of unknown etiology and is idiopathic in 25%- 50% cases. In approximately 50% of PG cases, an association with systemic diseases, such as Crohn's disease, monoclonal gammopathies, seropositive arthritis, collagenosis, Behcet&#...

Full description

Bibliographic Details
Main Authors: Carlos Jose Gaspar-Junior, Carlos Jose Gaspar
Format: Article
Language:English
Published: Sociedade Brasileira de Cirurgia Plástica 2018-12-01
Series:Revista Brasileira de Cirurgia Plástica
Subjects:
Online Access:http://www.rbcp.org.br/details/2227/pyoderma-gangrenosum-following-reduction-mammoplasty--a-case-report
_version_ 1827601423588655104
author Carlos Jose Gaspar-Junior
Carlos Jose Gaspar
author_facet Carlos Jose Gaspar-Junior
Carlos Jose Gaspar
author_sort Carlos Jose Gaspar-Junior
collection DOAJ
description Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis of unknown etiology and is idiopathic in 25%- 50% cases. In approximately 50% of PG cases, an association with systemic diseases, such as Crohn's disease, monoclonal gammopathies, seropositive arthritis, collagenosis, Behcet's disease, Wegener's granulomatosis, and myeloproliferative and infectious diseases (mainly hepatitis and AIDS), has been described. Clinically, PG presents four variants: ulcerated, bullous, vegetative, and pustular. The most frequent form is ulcerative, which begins as a papule or nodule and evolves rapidly into ulcerated and painful lesions. In approximately 25% of PG cases, the onset of new lesions can be triggered by traumas such as insect bites, intravenous injections, and biopsy, a phenomenon known as pathergy. Here, we present a case of extensive PG of the breasts following reductive mammoplasty surgery. It was a difficult case to diagnose and was initiated in the postoperative period of another service. Due to the breakdown of the doctor-patient relationship, the patient approached us for assistance. The patient showed an excellent response to corticotherapy (intra and perilesional corticotherapy with triamcinolone) during debridement and oral steroid (prednisone) therapy in the weaning phase.
first_indexed 2024-03-09T04:55:12Z
format Article
id doaj.art-8e90e52cbf1443ccb0762c40d6c43730
institution Directory Open Access Journal
issn 1983-5175
2177-1235
language English
last_indexed 2024-03-09T04:55:12Z
publishDate 2018-12-01
publisher Sociedade Brasileira de Cirurgia Plástica
record_format Article
series Revista Brasileira de Cirurgia Plástica
spelling doaj.art-8e90e52cbf1443ccb0762c40d6c437302023-12-03T13:06:06ZengSociedade Brasileira de Cirurgia PlásticaRevista Brasileira de Cirurgia Plástica1983-51752177-12352018-12-01330459059410.5935/2177-1235.2018RBCP0183Pyoderma gangrenosum following reduction mammoplasty: a case reportCarlos Jose Gaspar-Junior0Carlos Jose Gaspar1Faculdade de Medicina de Jundiaí, Jundiaí, SP, BrazilClínica Particular, Dermatologia e Medicina Interna, Osasco, SP, BrazilPyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis of unknown etiology and is idiopathic in 25%- 50% cases. In approximately 50% of PG cases, an association with systemic diseases, such as Crohn's disease, monoclonal gammopathies, seropositive arthritis, collagenosis, Behcet's disease, Wegener's granulomatosis, and myeloproliferative and infectious diseases (mainly hepatitis and AIDS), has been described. Clinically, PG presents four variants: ulcerated, bullous, vegetative, and pustular. The most frequent form is ulcerative, which begins as a papule or nodule and evolves rapidly into ulcerated and painful lesions. In approximately 25% of PG cases, the onset of new lesions can be triggered by traumas such as insect bites, intravenous injections, and biopsy, a phenomenon known as pathergy. Here, we present a case of extensive PG of the breasts following reductive mammoplasty surgery. It was a difficult case to diagnose and was initiated in the postoperative period of another service. Due to the breakdown of the doctor-patient relationship, the patient approached us for assistance. The patient showed an excellent response to corticotherapy (intra and perilesional corticotherapy with triamcinolone) during debridement and oral steroid (prednisone) therapy in the weaning phase.http://www.rbcp.org.br/details/2227/pyoderma-gangrenosum-following-reduction-mammoplasty--a-case-reportpyoderma gangrenosummammoplastyreconstructive surgical procedurespostoperative complicationsphysician-patient relationship
spellingShingle Carlos Jose Gaspar-Junior
Carlos Jose Gaspar
Pyoderma gangrenosum following reduction mammoplasty: a case report
Revista Brasileira de Cirurgia Plástica
pyoderma gangrenosum
mammoplasty
reconstructive surgical procedures
postoperative complications
physician-patient relationship
title Pyoderma gangrenosum following reduction mammoplasty: a case report
title_full Pyoderma gangrenosum following reduction mammoplasty: a case report
title_fullStr Pyoderma gangrenosum following reduction mammoplasty: a case report
title_full_unstemmed Pyoderma gangrenosum following reduction mammoplasty: a case report
title_short Pyoderma gangrenosum following reduction mammoplasty: a case report
title_sort pyoderma gangrenosum following reduction mammoplasty a case report
topic pyoderma gangrenosum
mammoplasty
reconstructive surgical procedures
postoperative complications
physician-patient relationship
url http://www.rbcp.org.br/details/2227/pyoderma-gangrenosum-following-reduction-mammoplasty--a-case-report
work_keys_str_mv AT carlosjosegasparjunior pyodermagangrenosumfollowingreductionmammoplastyacasereport
AT carlosjosegaspar pyodermagangrenosumfollowingreductionmammoplastyacasereport